$7.45
0.95% yesterday
Nasdaq, Nov 25, 09:45 pm CET
ISIN
US52634L1089
Symbol
LNSR

LENSAR Inc Stock price

$7.36
+2.06 38.87% 1M
+3.17 75.66% 6M
+3.85 109.69% YTD
+4.95 205.39% 1Y
+0.24 3.37% 3Y
-1.64 18.22% 5Y
-1.64 18.22% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.02 0.27%
ISIN
US52634L1089
Symbol
LNSR
Sector

Key metrics

Market capitalization $85.48m
Enterprise Value $83.07m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.70
P/S ratio (TTM) P/S ratio 1.75
P/B ratio (TTM) P/B ratio 3.76
Revenue growth (TTM) Revenue growth 21.29%
Revenue (TTM) Revenue $48.87m
EBIT (operating result TTM) EBIT $-8.61m
Free Cash Flow (TTM) Free Cash Flow $-6.61m
Cash position $18.08m
EPS (TTM) EPS $-1.46
P/E forward negative
P/S forward 1.65
EV/Sales forward 1.61
Short interest 0.52%
Show more

Is LENSAR Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

LENSAR Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a LENSAR Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a LENSAR Inc forecast:

Buy
100%

Financial data from LENSAR Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
49 49
21% 21%
100%
- Direct Costs 26 26
37% 37%
53%
23 23
7% 7%
47%
- Selling and Administrative Expenses 22 22
4% 4%
46%
- Research and Development Expense 5.46 5.46
13% 13%
11%
-4.86 -4.86
40% 40%
-10%
- Depreciation and Amortization 3.75 3.75
2% 2%
8%
EBIT (Operating Income) EBIT -8.61 -8.61
28% 28%
-18%
Net Profit -17 -17
28% 28%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about LENSAR Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LENSAR Inc Stock News

Neutral
Seeking Alpha
17 days ago
LENSAR, Inc. (NASDAQ:LNSR ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Cameron Radinovic - Investor Relations, Burns McClellan Nicholas Curtis - Chief Executive Officer Thomas Staab - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Operator Good morning, and thank you for participation. At this time, all pa...
Neutral
GlobeNewsWire
19 days ago
24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024
Neutral
GlobeNewsWire
25 days ago
ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors granted two newly-hired non-executive employees stock options to purchase an aggregate of 650 shares of the Company's common stock. The options were granted as of November 1, 2024, as inducements materi...
More LENSAR Inc News

Company Profile

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Head office United States
CEO Nicholas Curtis
Employees 130
Founded 2004
Website www.lensar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today